|
業務類別
|
-- |
|
業務概覽
|
Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company predominantly focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. The company mainly serves Finland but also has a presence in other European countries, North America and other countries. |
| 公司地址
| Orionintie 1, Espoo, FIN, FI-02200 |
| 電話號碼
| +358 104261 |
| 傳真號碼
| +358 104264435 |
| 公司網頁
| https://www.orion.fi |
| 員工數量
| 4003 |
| Mr. Rene Lindell |
Chief Financial Officer |
-- |
27/02/2026 |
| Ms. Liisa Hurme, PhD |
President and Chief Executive Officer |
-- |
27/02/2026 |
|
|
| Mr. Maziar Mike Doustdar |
Independent Director |
27/02/2026 |
| Mr. Henrik Stenqvist |
Independent Director |
27/02/2026 |
| Mr. Veli–Matti Mattila |
Chairman of the Board |
27/02/2026 |
| Mr. Kari Jussi Aho |
Independent Director |
27/02/2026 |
| Mr. Ari Lehtoranta |
Independent Director |
27/02/2026 |
| Ms. Hilpi Rautelin, M.D.,PhD |
Vice Chairman of the Board |
27/02/2026 |
| Ms. Eija Ronkainen, M.D. |
Independent Director |
27/02/2026 |
| Ms. Karen Lykke Sorensen |
Independent Director |
27/02/2026 |
|
|
|
|
